PBT up 15.7% despite EBITDA down 3.7%, with leverage stretched to 11.7x

What changed

Revenue rose 5.7% to $684.6m, but adjusted EBITDA fell 3.7% to $263.6m, indicating cost growth outpaced the top line at the operating level. Despite that, profit before tax rose 15.7% to $153.6m and NPAT rose 13.2% to $114.5m, implying a meaningful reduction in combined depreciation, amortisation and/or net interest below EBITDA. Capex rose modestly to $266.4m (38.9% of revenue versus 40.3% a year earlier). Cash fell to $24.7m from $31.8m, gross borrowings rose to $3.1b, and the interim dividend was held flat at 8.25c per share.

At segment level, Regulated Networks revenue grew to $422.7m (61.8% of group), but its reported result fell to $184.7m from $246.5m. Gas Trading result fell to $6.5m from $14.6m, and Metering fell to $39.1m from $83.1m. Group PBT nonetheless rose, which implies the remainder of the reconciliation (corporate, eliminations, non-segment items) moved materially in the group's favour.

What matters

• EBITDA-to-PBT divergence. EBITDA declined $10.2m but PBT rose $20.8m, a $31m swing from D&A and/or interest. The release excerpts do not disclose what drove that, but it is the main reason the headline NPAT looks stronger than the underlying operating trend.
• Leverage direction. Simple net debt (borrowings less cash) rose to roughly $3.1b from $3b, taking net debt / annualised adjusted EBITDA to approximately 11.7x from 10.9x. This is a regulated-utility capital structure, but the direction is still weakening during a period of elevated capex.
• Segment profit compression. Each disclosed segment recorded a lower result year on year, with Regulated Networks margin proxy falling from ~64.1% to ~43.7%. The group result therefore relies on items outside the three disclosed segments, which is an earnings-quality concern until reconciled.

Expectations

No quantified targets or forward-work figures were supplied. Seasonality context from FY21 shows HY21 contributed ~50.6% of full-year revenue, ~53.3% of EBITDA and ~52.3% of NPAT, i.e. FY21 was modestly first-half weighted. On that shape, a simple doubling of HY22 revenue implies a run-rate of about $1.4b, roughly 7.0% ahead of the $1.3b FY21 base. Applying the same first-half weighting to HY22 EBITDA would imply a full-year EBITDA below the FY21 $513.5m, given HY22 EBITDA is already down year on year. The release does not support a full-year upgrade thesis; it supports a flat-to-softer operating trajectory, offset below the EBITDA line.

Quality of result

The earnings growth is not coming from operating leverage. Revenue grew, EBITDA fell, and every disclosed segment result declined. The NPAT beat is therefore driven by below-EBITDA items, the nature of which is not disclosed in the supplied excerpts. The PBT/NPAT gap is modest (growth differential of 2.4pp, effective tax rate rising from 23.9% to 25.5%), so PBT is the cleaner read — and even PBT growth depends on the same below-EBITDA tailwind.

Working capital was broadly neutral: receivable days improved to ~22.3 from ~25.3, inventory days rose to ~4.0 from ~2.4, and operating working capital was essentially flat at ~$98.9m. Operating cash flow and free cash flow were not disclosed in the supplied pages, which is a material gap given capex of $266.4m exceeds reported NPAT by more than 2x. Cash conversion therefore cannot be assessed, but gross borrowings rising ~$110.8m alongside a dividend payment is consistent with capex not being fully self-funded.

Unresolved

• What drove the ~$31m combined reduction in D&A and net interest that flipped a weaker EBITDA into a stronger PBT? Is any portion non-recurring (e.g. capitalised interest, revaluation, asset life changes)?
• Why did every disclosed segment result decline while the group result rose? The reconciliation between segment results and group PBT is not visible in the excerpts.
• What were operating cash flow and free cash flow, and was the 8.25c interim dividend covered after capex, or funded from incremental borrowings?
• At 11.7x net debt/EBITDA and rising, what are the covenant and credit-rating headroom positions, and what is the glide path if EBITDA continues to soften?

This briefing cannot assess cash conversion, free cash flow adequacy, or the specific drivers of the below-EBITDA tailwind, because the supplied release excerpts do not contain the cash flow statement or a D&A/interest breakdown.

Key metrics

Segment breakdown

Analytical metrics

---

This analysis was generated using Annolyse, an AI-powered tool that analyses NZX company announcements. The analysis is based on available company filings and standard Annolyse calculations. This is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.